Stocks · Health care · Pharmaceutical Preparations

Q32 Bio Inc.

FIXX Clue Score74
United States Fiscal year ends December CIK 0001661998 Results filed 4 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Orbimed Advisors LLC
28 May 2026
Director
Buy indirect
625,000
$8.00
$5.00M
Orbimed Advisors LLC
28 May 2026
Director
Buy indirect
1,250,000
$8.00
$10.00M
Diyong Xu
28 May 2026
Director
Buy indirect
625,000
$8.00
$5.00M
Diyong Xu
28 May 2026
Director
Buy indirect
1,250,000
$8.00
$10.00M
James E Flynn
12 Apr 2019
Director
Buy indirect
533,333
$22.50
$12.00M
Temasek Holdings (Private) Ltd
2 Apr 2018
10% owner
Buy indirect
625,000
$16.00
$10.00M
Vida Ventures, LLC
2 Apr 2018
10% owner
Buy indirect
375,000
$16.00
$6.00M
Rock Springs Capital Management LP
2 Apr 2018
10% owner
Buy indirect
250,000
$16.00
$4.00M
James E Flynn
2 Apr 2018
Director
Buy indirect
625,000
$16.00
$10.00M
James E Flynn
2 Apr 2018
Director
Buy indirect
625,000
$16.00
$10.00M

What was left out

Form 4 filings counted 238
Amendments (4/A) skipped 15
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 1
Sales straight out of an exercise 22
Sales at will 99
Transactions with no price 0
Shares from compensation/vesting 34,811,374
Sales filed before the plan box existed 81
History held since 29 Mar 2018